Outcomes of Dual Umbilical Cord Blood Vs Mismatched Unrelated Donor Stem Cell Transplants with Post-Transplant Cyclophosphamide Based Graft-Versus-Host Disease Prophylaxis

Key Points

• Dual umbilical cord blood transplants lead to improved outcomes in graft-versus-host disease management, particularly in immunocompromised patients.
• Patients receiving dual umbilical cord blood transplants show a notable reduction in incidence rates of complications from mismatched donor transplants.
• Assessment using stem cell transplant records highlights the benefits of dual umbilical cord blood in treating hematologic malignancies rapidly.
• Further exploration into dual umbilical cord blood viability is needed to refine transplant protocols and enhance patient outcomes.